Adam Turner

Adam Turner is currently a Director at Deloitte, based in London, where they focus on the life sciences sector, particularly pharmaceuticals. Since 2022, they have managed audit engagements for FTSE 100 clients, including GSK and Oxford Nanopore Technologies. Adam previously held the role of Senior Manager at Deloitte from 2019 to 2022 and has experience in audit and reporting for both IPOs and Class 1 M&A transactions. They earned an MA (Hons) in Economics from the University of Cambridge in 2012 and completed their ACA qualification from the Institute of Chartered Accountants in England and Wales between 2013 and 2015.